Add-on Fasenra Does Not Ease COPD Exacerbations, Phase 3 Results Show
News
Add-on treatment with asthma medication Fasenra (benralizumab) failed to reduce annual exacerbations in patients with moderate to very severe chronic obstructive pulmonary disease (COPD), according to final results of two Phase ... Read more